WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier for pharmaceutical and biotech companies to connect real-world data with clinical research—helping them generate stronger evidence, faster. Thermo Fisher's PPD™ clinical research business and Datavant will enable secure connection and analysis of real-world data (RWD. ...

Core Insights - Datavant has partnered with Indegene to enhance recruitment for clinical studies, particularly focusing on rare diseases and complex conditions [1][2] - The collaboration aims to reduce screen failures and improve recruitment efficiency for biopharma companies [1][4] Partnership Details - The partnership leverages Datavant's data enrichment capabilities and Indegene's NEXT Patient Recruitment platform to facilitate quicker enrolment times and better decision-making in the recruitment process [2][5] - Datavant's health data retrieval network includes data from over 80,000 hospitals and clinics, processing over 100 million patient records annually [3] Expected Outcomes - The collaboration is expected to improve connections between eligible subjects and relevant clinical trials, addressing the challenge of finding enough patients for rare disease studies [4][5] - Indegene aims to enhance its digital-first recruitment solutions, integrating real-time access to consented patient medical records to minimize screen failures [5]

Core Insights - OneMedNet Corporation has expanded its capabilities within the Datavant Connect platform to enhance healthcare data discovery, analytics, and partner assessment processes, emphasizing the importance of secure and scalable data solutions in healthcare innovation [1][4] - The healthcare industry is generating vast amounts of health-related data, which is often fragmented and siloed, creating challenges in accessibility and usability [2][5] - OneMedNet will utilize AWS Clean Rooms to provide secure collaboration environments for data partner assessment, enhancing data security and privacy without direct data movement [3][4] Company Overview - OneMedNet is a leader in providing regulatory-grade imaging Real-World Data (iRWD), leveraging over 1,400 healthcare sites to unlock the potential of healthcare data [5] - The company’s iRWD™ platform supports various sectors, including rare diseases, oncology, and cardiology, delivering insights that drive innovation in patient care and healthcare disruption [5][6] - Beyond healthcare, OneMedNet's AI technology anonymizes data for other industries such as finance and retail, enabling secure data sharing and project de-risking [6]

Core Insights - OneMedNet has partnered with Datavant to enhance access to tokenized, purpose-built data for life sciences and medical research, leveraging a network of 31 million patients and over 121 million clinical studies [1][2] - The integration of OneMedNet's patient tokens into Datavant's ecosystem allows for easier discovery and access to Real-World Data, improving longitudinal data visibility and connectivity for researchers [2][3] - This collaboration emphasizes OneMedNet's leadership in medical innovation through AI and robust platforms, aiming to accelerate evidence-based solutions while ensuring data privacy [3] Company Overview - OneMedNet is transforming the utilization of Real-World Data (RWD) through its iRWD™ platform, which taps into over 1,400 healthcare sites, providing insights that drive innovation in drug development and patient care [4] - The company also applies its proprietary AI to anonymize data for various industries, including finance and retail, showcasing its versatility beyond healthcare [5]